Gene · 6472
Papers2,556
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 2,556
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LKB1 deficiency-induced metabolic reprogramming in tumorigenesis and non-neoplastic diseases. | Mol Metab | 2021 | 33278637 | PubTator, text mining | PubMed |
| The association between serine hydroxymethyl transferase 1 gene hypermethylation and ischemic stroke. | Bosn J Basic Med Sci | 2021 | 33259775 | PubTator, text mining | PubMed |
| Metabolic dysfunction and inflammatory disease: the role of stromal fibroblasts. | FEBS J | 2021 | 33251764 | PubTator, text mining | PubMed |
| A cell-nonautonomous mechanism of yeast chronological aging regulated by caloric restriction and one-carbon metabolism. | J Biol Chem | 2021 | 33243834 | PubTator, text mining | PubMed |
| Thrombospondin-1 is a prognostic biomarker and is correlated with tumor immune microenvironment in glioblastoma. | Oncol Lett | 2021 | 33240428 | PubTator, text mining | PubMed |
| Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis-Addicted Breast Tumor Growth. | Mol Cancer Ther | 2021 | 33203732 | PubTator, text mining | PubMed |
| Regulation of translation by one-carbon metabolism in bacteria and eukaryotic organelles. | J Biol Chem | 2021 | 33199376 | PubTator, text mining | PubMed |
| High-Throughput Screening Method for Directed Evolution and Characterization of Aldol Activity of D-Threonine Aldolase. | Appl Biochem Biotechnol | 2021 | 33015743 | PubTator, text mining | PubMed |
| Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. | J Cell Physiol | 2021 | 32959892 | PubTator, text mining | PubMed |
| Identification of three new compounds that directly target human serine hydroxymethyltransferase 2. | Chem Biol Drug Des | 2021 | 32779873 | PubTator, text mining | PubMed |
| SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemia. | Leukemia | 2021 | 32382081 | PubTator, text mining | PubMed |
| Proteomics-inspired precision medicine for treating and understanding multiple myeloma. | Expert Rev Precis Med Drug Dev | 2020 | 34414281 | PubTator, text mining | PubMed |
| Metformin: Targeting the Metabolo-Epigenetic Link in Cancer Biology. | Front Oncol | 2020 | 33604300 | PubTator, text mining | PubMed |
| The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. | Nat Cancer | 2020 | 33569544 | PubTator, text mining | PubMed |
| PHGDH as a mechanism for resistance in metabolically-driven cancers. | Cancer Drug Resist | 2020 | 33511334 | PubTator, text mining | PubMed |
| Metabolism of Amino Acids in Cancer. | Front Cell Dev Biol | 2020 | 33511116 | PubTator, text mining | PubMed |
| Definition of erythroid cell-positive blood transcriptome phenotypes associated with severe respiratory syncytial virus infection. | Clin Transl Med | 2020 | 33377660 | PubTator, text mining | PubMed |
| RRM2 protects against ferroptosis and is a tumor biomarker for liver cancer. | Cancer Cell Int | 2020 | 33372599 | PubTator, text mining | PubMed |
| Gene Polymorphisms Involved in Folate Metabolism and DNA Methylation with the Risk of Head and Neck Cancer. | Asian Pac J Cancer Prev | 2020 | 33369477 | PubTator, text mining | PubMed |
| From Glucose to Lactate and Transiting Intermediates Through Mitochondria, Bypassing Pyruvate Kinase: Considerations for Cells Exhibiting Dimeric PKM2 or Otherwise Inhibited Kinase Activity. | Front Physiol | 2020 | 33335484 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6472/papers?page=43